Rtw Investments, LP Prometheus Biosciences, Inc. Transaction History

Rtw Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$103.46 - $126.29 $8.5 Million - $10.4 Million	-82,199 Reduced 2.45%	3,272,104 $351 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $5.94 Million - $19.3 Million	164,698 Added 5.16%	3,354,303 $369 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $9.66 Million - $16.8 Million	431,658 Added 15.65%	3,189,605 $90 Million
Q1 2022 May 16, 2022	SELL	$30.13 - $50.0 $15.2 Million - $25.3 Million	-506,084 Reduced 15.5%	2,757,947 $104 Million
Q1 2021 May 14, 2021	BUY	$16.51 - $25.29 $53.9 Million - $82.5 Million	3,264,031 New	3,264,031 $51.7 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.